These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 18473952)

  • 1. Advanced glycation: implications in tissue damage and disease.
    Gasser A; Forbes JM
    Protein Pept Lett; 2008; 15(4):385-91. PubMed ID: 18473952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential role of advanced glycosylation end products in promoting restenosis in diabetes and renal failure.
    Aronson D
    Med Hypotheses; 2002 Sep; 59(3):297-301. PubMed ID: 12208156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics, role and therapeutic implications of endogenous soluble form of receptor for advanced glycation end products (sRAGE) in diabetes.
    Yamagishi S; Matsui T; Nakamura K
    Curr Drug Targets; 2007 Oct; 8(10):1138-43. PubMed ID: 17979674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced glycation end-products: implications for diabetic and non-diabetic nephropathies.
    Daroux M; Prévost G; Maillard-Lefebvre H; Gaxatte C; D'Agati VD; Schmidt AM; Boulanger E
    Diabetes Metab; 2010 Feb; 36(1):1-10. PubMed ID: 19932633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between advanced glycation end-products (AGE) and their receptors in the development and progression of diabetic nephropathy - are these receptors valid therapeutic targets.
    Sourris KC; Forbes JM
    Curr Drug Targets; 2009 Jan; 10(1):42-50. PubMed ID: 19149535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical review: The role of advanced glycation end products in progression and complications of diabetes.
    Goh SY; Cooper ME
    J Clin Endocrinol Metab; 2008 Apr; 93(4):1143-52. PubMed ID: 18182449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of advanced glycation end products (AGEs) in osteoporosis in diabetes.
    Yamagishi S
    Curr Drug Targets; 2011 Dec; 12(14):2096-102. PubMed ID: 22023404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of receptors for advanced glycation end-products in occlusive vascular and renal disease.
    Bierhaus A; Ritz E; Nawroth PP
    Nephrol Dial Transplant; 1996; 11 Suppl 5():87-90. PubMed ID: 9044315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced glycation end products and insulin resistance.
    Unoki H; Yamagishi S
    Curr Pharm Des; 2008; 14(10):987-9. PubMed ID: 18473850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation.
    Ramasamy R; Vannucci SJ; Yan SS; Herold K; Yan SF; Schmidt AM
    Glycobiology; 2005 Jul; 15(7):16R-28R. PubMed ID: 15764591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of AGEs in aging: causation or correlation.
    Baynes JW
    Exp Gerontol; 2001 Sep; 36(9):1527-37. PubMed ID: 11525875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The receptor for advanced glycation end-products has a central role in mediating the effects of advanced glycation end-products on the development of vascular disease in diabetes mellitus.
    Hori O; Yan SD; Ogawa S; Kuwabara K; Matsumoto M; Stern D; Schmidt AM
    Nephrol Dial Transplant; 1996; 11 Suppl 5():13-6. PubMed ID: 9044300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes.
    Yamagishi S
    Exp Gerontol; 2011 Apr; 46(4):217-24. PubMed ID: 21111800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Glycation Angle to Look into the Diabetic Vasculopathy: Cause and Cure.
    Ahmad S; Siddiqui Z; Rehman S; Khan MY; Khan H; Khanum S; Alouffi S; Saeed M
    Curr Vasc Pharmacol; 2017; 15(4):352-364. PubMed ID: 28356033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced glycation end products (AGEs) and their involvement in liver disease.
    Hyogo H; Yamagishi S
    Curr Pharm Des; 2008; 14(10):969-72. PubMed ID: 18473847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced glycation end products: a link between periodontitis and diabetes mellitus?
    Gurav AN
    Curr Diabetes Rev; 2013 Sep; 9(5):355-61. PubMed ID: 23845077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Non-enzymatic glycation and oxidative stress in chronic illnesses and diabetes mellitus].
    Nawroth PP; Bierhaus A; Vogel GE; Hofmann MA; Zumbach M; Wahl P; Ziegler R
    Med Klin (Munich); 1999 Jan; 94(1):29-38. PubMed ID: 10081287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic kidney disease: a role for advanced glycation end-product receptor 1 (AGE-R1)?
    Zhuang A; Forbes JM
    Glycoconj J; 2016 Aug; 33(4):645-52. PubMed ID: 27270766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications.
    Wautier JL; Wautier MP; Schmidt AM; Anderson GM; Hori O; Zoukourian C; Capron L; Chappey O; Yan SD; Brett J
    Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7742-6. PubMed ID: 8052654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced glycation end products and the progressive course of renal disease.
    Heidland A; Sebekova K; Schinzel R
    Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S100-6. PubMed ID: 11576932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.